One-Page Truth-Telling Aid for Cancer Disclosure
A One-Page Truth-Telling Aid for Cancer Disclosure in Taiwan: A Two-Arm Pragmatic Randomized Controlled Trial
The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation.
The main questions it aims to answer are:
- Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained?
- Does the one-page communication aid reduce patients' emotional distress after the consultation?
- Does the one-page communication aid improve physicians' confidence in communicating cancer-related information?
Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence.
Participants will:
- Complete questionnaires before and after the consultation
- Receive either the one-page communication aid or a blank sheet, depending on their physician's group
- Complete follow-up questionnaires at 3 months and 6 months after the consultation
Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Cancer-related truth-telling is an important but challenging part of oncology care. Patients may differ in how much information they want to receive, how they prefer information to be explained, who they want to be present during the discussion, and what questions or concerns they wish to raise. In routine outpatient settings, physicians often have limited time to identify these individual preferences before discussing cancer-related information.
This study will evaluate a One-Page Truth-Telling Aid designed to help physicians quickly understand patients' disclosure preferences and communication needs before the consultation. The aid is completed with patients before the visit and summarizes key information for the physician, including the patient's preferred way of receiving information, preferred communication style, desired content, and questions the patient would like to ask.
This is a two-arm, single-blind, pragmatic clinical trial. Participating physicians will be assigned to either the experimental group or the control group. Patients will be allocated according to the group assignment of their participating physician. Patients in the experimental group will complete the One-Page Truth-Telling Aid before the consultation and will be encouraged to provide it to their physician at the beginning of the visit. Patients in the control group will receive a blank sheet that they may use to write down questions before the consultation.
The study will assess patient-reported truth-telling experiences, emotional distress, and decisional regret, as well as physician-reported communication confidence. Patient assessments will be conducted before the consultation, immediately after the consultation, and at 3 and 6 months after the consultation. Physician assessments will be conducted before the intervention, 1 week after recruitment of their first enrolled patient, and at 3 and 6 months thereafter.
The study is expected to provide evidence on whether a brief, low-burden communication aid can support patient-centered truth-telling in oncology outpatient care and improve communication-related outcomes for both patients and physicians.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Shih-Ying Chen, PhD
- Número de telefone: +886-32118800 #5212
- E-mail: s26871193@cgu.edu.tw
Locais de estudo
-
-
-
Taoyuan, Taiwan, 33302
- Recrutamento
- Chang Gung University
-
Contato:
- Shih-Ying Chen, PhD
- Número de telefone: +886-32118800 #5212
- E-mail: s26871193@cgu.edu.tw
-
Investigador principal:
- Shih-Ying Chen, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
【Physicians】
Inclusion Criteria:
- Physicians who provide clinical care for patients with cancer in participating outpatient departments.
- Physicians who are involved in cancer-related truth-telling or disclosure consultations.
- Physicians who are willing to participate and provide informed consent.
Exclusion Criteria:
- Physicians who are unable or unwilling to complete study procedures or follow-up assessments.
【Patients】
Inclusion Criteria:
- Patients diagnosed with cancer.
- Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status.
- Patients who are able to communicate in Mandarin Chinese or Taiwanese.
- Patients who are able to complete questionnaires independently or with assistance from the research assistant.
- Patients who are willing to participate and provide informed consent.
Exclusion Criteria:
- Patients who are unable to provide informed consent.
- Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff.
- Patients who are unable to complete the study questionnaires even with assistance.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: One-Page Truth-Telling Aid
Patients in this arm will receive the One-Page Truth-Telling Aid before the truth-telling consultation.
The aid will be completed with the patient before the visit and summarizes the patient's disclosure preferences, communication needs, and questions for the physician.
Patients will be encouraged to provide the aid to their participating physician at the beginning of the consultation so that the physician can quickly understand the patient's preferences and tailor communication accordingly.
|
The One-Page Truth-Telling Aid is a brief communication aid completed with patients before the consultation.
It summarizes patients' disclosure preferences, communication needs, and questions for the physician.
Patients are encouraged to provide the aid to their participating physician at the beginning of the consultation to support patient-centered communication.
|
|
Comparador Ativo: Blank Sheet
Patients in this arm will receive a blank sheet before the truth-telling consultation.
The blank sheet may be used to write down questions or concerns the patient would like to discuss with the physician.
It does not include structured questions about disclosure preferences or communication needs.
Patients will receive usual care and may choose whether to provide the blank sheet to their participating physician during the consultation.
|
The blank sheet is provided to patients before the consultation and may be used to write down questions or concerns.
It does not include structured questions about disclosure preferences or communication needs.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patients' Truth-Telling Preferences and Perceptions
Prazo: Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention
|
Patients' truth-telling preferences and perceptions of physicians' actual disclosure practices will be assessed using the 43-item Truth-Telling Questionnaire (TTQ-43).
The TTQ-43 includes four domains: how to deliver bad news, emotional support, additional information, and setting.
Items are scored from 1 to 5, with higher scores indicating stronger preferences expectation at baseline or greater perceived alignment with physician practice at follow-up.
|
Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patients' Psychological Distress
Prazo: Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention
|
Patients' psychological distress will be assessed using the Depression Anxiety Stress Scale-21 (DASS-21). The DASS-21 includes three subscales: depression, anxiety, and stress. Each subscale score ranges from 0 to 42, with higher scores indicating greater symptom severity. Patients' psychological distress will also be assessed using the Distress Thermometer (DT), a single-item distress screening tool. Scores range from 0 to 10, with higher scores indicating greater distress. A score of 4 or higher indicates clinically relevant distress. |
Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention
|
|
Physicians' Confidence in Communication
Prazo: Baseline, 1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention
|
Physicians' confidence in communication with patients with cancer and their families will be assessed using the 21-item Confidence in Communication with Patients questionnaire.
Items are scored from 1 to 10, with higher scores indicating greater confidence.
|
Baseline, 1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention
|
|
Patients' Decision Regret
Prazo: 3 months post-intervention and 6 months post-intervention
|
Patients' regret regarding their treatment decisions will be assessed using the Decision Regret Scale (DRS).
Scores range from 0 to 100, with higher scores indicating greater decisional regret.
A score greater than 25 indicates moderate to high decisional regret.
|
3 months post-intervention and 6 months post-intervention
|
|
Treatment-Related Adverse Events
Prazo: 3 months post-intervention and 6 months post-intervention
|
Treatment-related adverse events will be evaluated using the Common Terminology Criteria for Adverse Events version 5.0 (CTCAE v5.0) based on electronic health record data.
Events are graded from 1 to 5, with higher grades indicating more severe adverse events.
|
3 months post-intervention and 6 months post-intervention
|
|
Medical Expenditure
Prazo: 6 months post-intervention
|
Medical expenditure will be estimated using National Health Insurance points recorded in the electronic health record system, based on the local conversion basis in Taiwan.
|
6 months post-intervention
|
|
Physicians' Perceived Usefulness of the One-Page Truth-Telling Aid
Prazo: 1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention
|
Physicians' perceived usefulness of the One-Page Truth-Telling Aid will be assessed using a single-item rating scale from 0 to 10, with higher scores indicating greater perceived usefulness.
|
1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention
|
|
Physicians' Willingness to Recommend the One-Page Truth-Telling Aid
Prazo: 1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention
|
Physicians' willingness to recommend the One-Page Truth-Telling Aid will be assessed using a single-item rating scale from 0 to 10, with higher scores indicating greater willingness to recommend the aid.
|
1 week after recruitment of the physician's first enrolled patient, 3 months post-intervention, and 6 months post-intervention
|
|
Patients' Trust in the Physician and Satisfaction With the Disclosure Experience
Prazo: Immediately after the truth-telling consultation
|
Patients' trust in the physician and satisfaction with the disclosure experience will be assessed using single-item rating scales from 0 to 10, with higher scores indicating greater trust and satisfaction.
|
Immediately after the truth-telling consultation
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Shih-Ying Chen, PhD, Chang Gung University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- NSTC 114-2635-B-182-002 -
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .